Found 26 matching trials
Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma NA Temsirolimus is a drug that is being studied to possibly treat kidney cance...
Show More Location
St. Joseph's Healthcare Hamilton
Learn More & Join Trial
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial PHASE3 This phase III trial compares the effect of adding surgery to a standard of...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery PHASE3 Two randomized trials in the cytokine era clearly showed that cytoreductive...
Show More Location
Fondazione IRCCS Istituto Nazionale Tumori
Learn More & Join Trial
Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer PHASE2 Sorafenib may stop the growth of tumor cells by blocking some of the enzyme...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC) PHASE2 The goal of this clinical research study is to learn if Sutent® (sunitinib ...
Show More Status
Active Not Recruiting
Location
Baylor College of Medicine
Learn More & Join Trial
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition PHASE2 The purpose of this study is to determine if the use of immunotherapy nivol...
Show More Status
Active Not Recruiting
Location
The Rutgers Cancer Institute of New Jersey
Learn More & Join Trial
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer PHASE2 Phase II, multicenter, national, uncontrolled, multicenter, uncontrolled, p...
Show More Location
Institut Català d'Oncologia. Idibell
Learn More & Join Trial
Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma N/A This local, prospective, multicenter, non-interventional study documents ob...
Show More Location
Multiple Locations
Learn More & Join Trial
Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO) PHASE2 The PLUTO-trial is a single-center, open-label, phase II trial investigatin...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
Learn More & Join Trial
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery PHASE2 This phase II trial studies how well pembrolizumab with or without standard...
Show More Location
University of California, San Francisco
Learn More & Join Trial